21 November 2024
\n \n \n \nBringing together researchers from across our department and University, our second Research Showcase celebrated collaboration, innovation, and a shared commitment to closing historical gaps in health research to transform care for women.
\n \n\n \n \n21 November 2024
\n \n \n \nResearchers revise findings on unexpected weight loss as a cancer indicator, with new analysis of 326,000 patient records showing higher cancer risk than previously reported. Updated guidance suggests when GPs should investigate weight loss in patients.
\n \n\n \n \n20 November 2024
\n \n \n \nDiscover how our researchers are transforming COPD care while addressing antimicrobial resistance (AMR) through innovative approaches \u2013 from smart inhalers to AI analysis \u2013 helping millions living with lung conditions in the UK
\n \n\n \n \n19 November 2024
\n \n \n \nProfessor Anthony Harnden, of Nuffield Department of Primary Care Health Sciences, University of Oxford, and former Deputy Chair of the Joint Committee on Vaccination and Immunisation (JCVI), has been appointed Chair of the UK\u2019s Medicines and Healthcare products Regulatory Agency (MHRA).
\n \n\n \n \n8 November 2024
\n \n \n \nAnalysis of 17.5 million health records reveals significant ethnic and social inequalities in lung cancer diagnosis. Research shows Bangladeshi men face highest risks, while people in deprived areas are twice as likely to develop lung cancer compared to affluent areas. Important implications for NHS screening.
\n \n\n \n \n6 November 2024
\n \n \n \nA new online toolkit, Paramedics in Primary Care, has been launched to help patients, paramedics and General Practitioners (GPs) support the evolving role of paramedics within primary care settings.
\n \n\n \n \n28 October 2024
\n \n \n \nTeaching for the new academic year is well underway across the Nuffield Department of Primary Care Health Sciences on our Master's and DPhil courses, as well as for the undergraduate curriculum. \r\n\r\nHere we bring a round-up of the welcome and induction activities taking place for our programmes.
\n \n\n \n \n21 October 2024
\n \n \n \nWe are delighted to share that Professor Sir Aziz Sheikh OBE, NDPCHS Head of Department and Nuffield Professor of Primary Care Health Sciences, has been elected to the esteemed National Academy of Medicine (NAM) in the United States.
\n \n\n \n \n11 October 2024
\n \n \n \nOxford Primary Care Undergraduate Teaching Team pays tribute to Martin Lawrence's legacy, visiting his family as applications for the scholarship in his name commence.
\n \n\n \n \n11 October 2024
\n \n \n \nResearchers from the Cancer Theme at Nuffield Department of Primary Care Health Sciences (NDPCHS) and Department of Oncology at the University of Oxford, report that cancer data collected by national cancer registries is comparable to the data gathered directly by researchers in clinical studies. This could make cancer research much easier and less expensive in the future.
\n \n\n \n \n4 October 2024
\n \n \n \nWe\u2019re proud to congratulate our Interdisciplinary Research in Health Sciences (IRIHS) group for winning the Royal College of General Practitioners (RCGP) Health Services Research Paper of the Year award. The team was honoured for their innovative study titled Patient safety in remote primary care encounters: multimethod qualitative study combining Safety I and Safety II analysis, published in BMJ Quality and Safety.
\n \n\n \n \n3 October 2024
\n \n \n \nA new study, published in the British Journal of General Practice, has used the OpenSAFELY platform to uncover significant inequalities in risk of rapid weight gain among adults with type 2 diabetes or hypertension during the COVID-19 pandemic in England.
\n \n\n \n \n1 October 2024
\n \n \n \nResearchers from NDPCHS have found that a widely used heart medication, spironolactone, does not help prevent heart problems in people with chronic kidney disease (CKD). The study, published in Nature Medicine, found no significant benefit from the drug and highlighted safety concerns that led many patients to stop the treatment.
\n \n\n \n \n1 October 2024
\n \n \n \nDr. Anne-Marie Boylan, Senior Researcher in the Centre for Evidence Based Medicine, featured in a BBC Panorama investigation examining menopause products and their scientific backing.
\n \n\n \n \n1 October 2024
\n \n \n \nProfessor Sir Aziz Sheikh takes over the role of Head of Department from Professor Richard Hobbs CBE from 1 October 2024
\n \n\n \n \n27 September 2024
\n \n \n \nFor over a decade, The University of Oxford's Alumni Weekend, Meeting Minds, has been bringing alumni back from all corners of the globe to inspire, entertain and delight through lectures, tours and music. This year Meeting Minds was held on the weekend of 20-22 September, in many venues across Oxford.
\n \n\n \n \n27 September 2024
\n \n \n \nMSc in Global Healthcare Leadership student Gurpreet Singh Kalra recently spoke at the Sa\u00efd Business School, addressing women\u2019s reproductive health in the workplace.
\n \n\n \n \n10 September 2024
\n \n \n \nCan the long-term consequences of COVID 19 be reduced through the use of novel antiviral medicines? New research from the PANORAMIC trial, run in NDPCHS Clinical Trial Unit and funded and delivered by the NIHR, has found that treating vaccinated, higher-risk adults with COVID-19 with the antiviral drug molnupiravir offers only modest benefits when it comes to reducing long term effects of the acute illness.
\n \n\n \n \n9 September 2024
\n \n \n \nWe are now inviting applications for all of our postgraduate programmes based within the department for 2025.
\n \n\n \n \n5 September 2024
\n \n \n \nTop three strategies for quitting smoking: e-cigarettes, varenicline, and cytisine. New review summarises data from fourteen Cochrane Tobacco Addiction Reviews of over 150,000 participants, providing evidence-based guidance for smokers seeking to quit.
\n \n\n \n \n